Concepedia

Susanne Ostrowitzki

SO

Statistics

Publications

33

Citations

2.9K

H-Index

23

Active since

1993

Affiliations

Roche (Switzerland)(Current)

Roche (United Kingdom)

Fundació ACE

Johns Hopkins University

University of California, San Francisco

Susanne Ostrowitzki is an author at Roche (Switzerland) specializing in medicine, pharmacology, and neurodegenerative diseases.

Publications per year

1993–2025

33

Publications

33

A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease

Susanne Ostrowitzki, Robert Lasser, Ernest Dorflinger et al. · Alzheimer s Research & Therapy · 2017 · 568 citations · Full text

, , +17

Mechanism of Amyloid Removal in Patients With Alzheimer Disease Treated With Gantenerumab

Susanne Ostrowitzki · Archives of Neurology · 2011 · 442 citations

, , +17

Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti–α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease

Joseph Jankovic, Ira Goodman, Beth Safirstein et al. · JAMA Neurology · 2018 · 292 citations · Full text

, , +17

First‐in‐human assessment of PRX002, an anti–α‐synuclein monoclonal antibody, in healthy volunteers

Dale B. Schenk, Martin Koller, Daniel Ness et al. · Movement Disorders · 2016 · 248 citations · Full text

, , +17

Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease

Susanne Ostrowitzki, Tobias Bittner, Kaycee M. Sink et al. · JAMA Neurology · 2022 · 224 citations · Full text

, , +17

1–5 of 33